COOL JAPAN FUND

MENU
ロゴ Spiber

Number

28

Lifestyle

Investment in Spiber’s Apparel Business Utilizing Next Generation Fiber Materials Developed in Japan
― New Synthetic Protein Materials Based on Engineered Spider Silk DNA ―

Enterprises : Spiber Inc.

WEB SITE

Overview / Policy implications

Spiber, a biotech venture company launched out of the Keio University Institute for Advanced Biosciences in 2007, engages in the development and production of synthetic proteins based on engineered spider silk DNA. Funds raised from this round, in which Cool Japan Fund was the lead investor, will be used to propel Spiber’s transition into the commercialization phase.

The funds will be utilized for the planned construction of the company’s first mass-production plant, to be located in Thailand. Cool Japan Fund aims to increase global awareness of Japan’s cutting-edge material and fiber development manufacturing initiatives and cultivate new demand in the international fashion and apparel markets.

Business Expansion
The pilot fermentation plant at Spiber’s Tsuruoka headquarters (©Spiber Inc.)”

An improved MOON PARKA® prototype undergoing testing (©Spiber Inc.)

An improved MOON PARKA® prototype undergoing testing (©Spiber Inc.)

Gene synthesis room (©Spiber Inc.)

Gene synthesis room (©Spiber Inc.)”

The pilot fermentation plant at Spiber’s Tsuruoka headquarters (©Spiber Inc.)

Spun yarn sample (©Spiber Inc.)

Spun yarn sample (©Spiber Inc.)

Filament yarn sample (©Spiber Inc.)

Filament yarn sample (©Spiber Inc.)

See other projects

Cool Japan Fund Inc.
17F Roppongi Hills Mori Tower, 6-10-1, Roppongi, Minato-ku, Tokyo, 106-6117, Japan
TEL:+81(0)3-6406-7500 FAX:+81(0)3-6406-7501

© 2019 Cool Japan Fund Inc. All Rights Reserved.

CLOSE
close

Shareholders